세계의 외골격 시장 : 재료별, 구조별, 모빌리티별, 신체 부위별, 구성요소별, 유형별, 업계별, 지역별 - 예측(-2030년)

The exoskeleton market is estimated to be USD 0.56 billion in 2025 and is projected to reach USD 2.03 billion by 2030, registering a CAGR of 29.4% during the forecast period. Exoskeletons are important for improving mobility for people with physical impairment and reducing physical strain for industrial workers, leading to the integration of exoskeletons in healthcare and manufacturing. As the elderly population increases and patients at home for rehabilitation become more prevalent, the need for exoskeletons will only rise. As more technologies become available (AI, sensors, lightweight materials), exoskeleton products will function better, cheaper, and be more available. The process of product development and the growth of the exoskeleton market internationally will only be improved by continued investments by both the public and private sectors.

"Powered exoskeleton segment to register the highest CAGR during the forecast period."

The market for powered exoskeletons is experiencing accelerated growth, fueled by significant funding activities that underscore rising investor confidence and commercialization potential. For instance, in December 2023, German Bionic, a developer of electrically powered exoskeletons, secured more than USD 16.3 million in an expanded Series A funding round. This funding is aimed at strengthening the company's collaboration with its industrialization partner, Mubea, to scale production and improve deployment capabilities. In the same month, Verve Motion, a Cambridge-based startup specializing in robotic exosuits designed to enhance the physical capabilities of workers in demanding roles, successfully raised USD 20 million in a Series B funding round. These developments reflect a broader trend of strategic investments in powered exoskeleton technologies, positioning them as viable solutions for industrial automation, injury prevention, and workforce augmentation across various sectors.

"Industrial vertical to register the second-highest CAGR during the forecast period."

The industrial sector is rapidly emerging as a significant adopter of exoskeleton technology, driven by the need to improve worker safety, reduce fatigue, and increase productivity in labor-intensive environments. Exoskeletons are particularly useful in industries such as manufacturing, warehousing, logistics, and assembly lines, where workers often perform repetitive lifting, bending, and overhead tasks. By supporting the lower back, shoulders, and legs, these wearable devices help reduce the risk of musculoskeletal injuries, one of the most common causes of lost workdays and rising occupational health costs.

"Germany to dominate European exoskeleton market."

Germany represents one of the most advanced and mature markets for exoskeleton technology in Europe, driven by strong industrial demand, innovation in healthcare, and significant private investments. The country's robust manufacturing and logistics sectors are actively adopting exoskeletons to improve workforce efficiency and reduce musculoskeletal injuries. German Bionic, a leading domestic developer, exemplifies this trend. In December 2023, the company raised over USD 16.3 million in an expanded Series A funding round to advance its product portfolio. Its exoskeletons, Apogee and Apogee+, are used in logistics, retail, and healthcare settings to assist with lifting, walking, and posture correction. These connected wearables are helping redefine workplace ergonomics across Germany's key industries.

• By Company Type: Tier 1 - 25%, Tier 2 - 40%, and Tier 3 - 35%
• By Designation: C-level Executives - 30%, Directors - 28%, and Others - 42%
• By Region: North America- 43%, Europe - 15%, Asia Pacific- 37%, and RoW- 05%

Ekso Bionics (US), Ottobock (Germany), DIH Medical (Switzerland), Comau (Italy), Myomo Inc. (US), CYBERDYNE Inc. (Japan), Lifeward Ltd. (Israel), Hyundai Motor Group Robotics LAB. (South Korea), B-Temia (Canada), Rex Bionics Ltd. (New Zealand), ABLE Human Motion (Spain), Laevo Exoskeletons (Netherlands), German Bionic Systems GmbH (Germany), and Levitate Technologies, Inc. (US) are some of the key players in the exoskeleton market.

The study includes an in-depth competitive analysis of these key players in the exoskeleton market, with their company profiles, recent developments, and key market strategies.

Research Coverage

This research report categorizes the exoskeleton market by component (hardware, software), type (powered, passive, hybrid), body part (lower extremities, upper extremities, full body), structure (rigid, soft), mobility (stationary, mobile), vertical (healthcare, defense, industrial, construction, other verticals), and region (North America, Europe, Asia Pacific, and RoW). The report's scope covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the exoskeleton market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies (contracts, partnerships, agreements, new product launches, mergers & acquisitions); and recent developments associated with the exoskeleton market. This report covers the competitive analysis of upcoming startups in the exoskeleton market ecosystem.

Reasons to Buy This Report

The report will help market leaders and new entrants with information on the closest approximations of the revenue numbers for the overall exoskeleton market and its subsegments. It will also help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

• Analysis of key drivers (Rising demand for robotic rehabilitation solutions from healthcare sector, Increased adoption in industrial and manufacturing sectors, Increased FDA approvals for medical exoskeletons), restraints (High cost of ownership), opportunities (Integration of exoskeletons with AI and IoT technologies, Increasing adoption of exoskeletons in military and defense sector), and challenges (Comfort and movement interference for workers, Power supply limitations and operational downtime) influencing the growth of the exoskeleton market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the exoskeleton market
• Market Development: Comprehensive information about lucrative markets - the report analyses the exoskeleton market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the exoskeleton market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Ekso Bionics (US), Ottobock (Germany), DIH Medical (Switzerland), Comau (Italy), Myomo Inc. (US), CYBERDYNE Inc. (Japan), Lifeward Ltd. (Israel), Hyundai Motor Group Robotics LAB. (South Korea), B-Temia (Canada), Rex Bionics Ltd. (New Zealand), ABLE Human Motion (Spain), Laevo Exoskeletons (Netherlands), German Bionic Systems GmbH (Germany), Levitate Technologies, Inc. (US), among others in the exoskeleton market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE
  • 1.3.2 YEARS CONSIDERED
  • 1.3.3 INCLUSIONS AND EXCLUSIONS
• 1.4 CURRENCY CONSIDERED
• 1.5 UNITS CONSIDERED
• 1.6 LIMITATIONS
• 1.7 STAKEHOLDERS
• 1.8 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 List of major secondary sources
    • 2.1.1.2 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Intended participants and key opinion leaders in primary interviews
    • 2.1.2.2 List of major participants in primary interviews
    • 2.1.2.3 Key data from primary sources
    • 2.1.2.4 Breakdown of primary interviews
  • 2.1.3 SECONDARY AND PRIMARY RESEARCH
    • 2.1.3.1 Key industry insights
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.1.1 Approach to arrive at market size using bottom-up analysis (demand side)
  • 2.2.2 TOP-DOWN APPROACH
    • 2.2.2.1 Approach to arrive at market size using top-down analysis (supply side)
• 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
• 2.4 RESEARCH ASSUMPTIONS
• 2.5 RESEARCH LIMITATIONS
• 2.6 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN EXOSKELETON MARKET
• 4.2 EXOSKELETON MARKET IN NORTH AMERICA, BY COUNTRY AND VERTICAL
• 4.3 EXOSKELETON MARKET IN ASIA PACIFIC, BY VERTICAL
• 4.4 EXOSKELETON MARKET, BY COUNTRY

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Rising demand for robotic rehabilitation solutions from healthcare sector
    • 5.2.1.2 Increased adoption in industrial and manufacturing sectors
    • 5.2.1.3 Increased FDA approvals for medical exoskeletons
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High cost of ownership
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Integration of exoskeletons with AI and IoT technologies
    • 5.2.3.2 Increasing adoption of exoskeletons in military and defense sectors
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Comfort and movement interference for workers
    • 5.2.4.2 Power supply limitations and operational downtime
• 5.3 VALUE CHAIN ANALYSIS
• 5.4 ECOSYSTEM ANALYSIS
• 5.5 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 5.6 PRICING ANALYSIS
  • 5.6.1 PRICING RANGE OF EXOSKELETON OFFERED BY KEY PLAYERS, BY TYPE, 2024
  • 5.6.2 AVERAGE SELLING PRICE TREND OF EXOSKELETON, BY TYPE, 2022-2024
  • 5.6.3 AVERAGE SELLING PRICE TREND OF POWERED EXOSKELETON, BY REGION, 2022-2024
  • 5.6.4 AVERAGE SELLING PRICE TREND OF PASSIVE EXOSKELETON, BY REGION, 2022-2024
• 5.7 TECHNOLOGY ANALYSIS
  • 5.7.1 KEY TECHNOLOGIES
    • 5.7.1.1 Actuators and motors
    • 5.7.1.2 Sensors and feedback systems
  • 5.7.2 COMPLEMENTARY TECHNOLOGIES
    • 5.7.2.1 IoT connectivity
    • 5.7.2.2 AI and ML
  • 5.7.3 ADJACENT TECHNOLOGIES
    • 5.7.3.1 Artificial muscles
    • 5.7.3.2 Physical therapy equipment
• 5.8 PORTER'S FIVE FORCES ANALYSIS
  • 5.8.1 INTENSITY OF COMPETITIVE RIVALRY
  • 5.8.2 BARGAINING POWER OF SUPPLIERS
  • 5.8.3 BARGAINING POWER OF BUYERS
  • 5.8.4 THREAT OF SUBSTITUTES
  • 5.8.5 THREAT OF NEW ENTRANTS
• 5.9 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.9.2 BUYING CRITERIA
• 5.10 CASE STUDY ANALYSIS
  • 5.10.1 ENHANCING WORKER ERGONOMICS AND PRODUCTIVITY AT JOHN DEERE WITH COMAU'S MATE-XT WEARABLE EXOSKELETON
  • 5.10.2 ENHANCING LOGISTICS OPERATIONS AND WORKER WELL-BEING AT FIEGE GROUP WITH GERMAN BIONIC AI-POWERED EXOSKELETON TECHNOLOGY
  • 5.10.3 ENHANCING WORKER SAFETY AND PRODUCTIVITY IN TUNNEL CONSTRUCTION AT GRANITE CONSTRUCTION WITH LEVITATE TECHNOLOGIES EXOSKELETONS
  • 5.10.4 REDUCING PHYSICAL STRAIN IN TRUCK MAINTENANCE AT MAN TRUCK & BUS WITH HELP OF SUITX TECHNOLOGY BY OTTOBOCK
  • 5.10.5 FORD MOTOR COMPANY ENHANCES WORKER SAFETY AND REDUCES INJURIES WITH EKSO BIONICS EKSOVEST
• 5.11 INVESTMENT AND FUNDING SCENARIO
• 5.12 TRADE ANALYSIS, 2020-2024
  • 5.12.1 IMPORT SCENARIO (HS CODE 9021)
  • 5.12.2 EXPORT SCENARIO (HS CODE 9021)
• 5.13 PATENT ANALYSIS
• 5.14 KEY CONFERENCES AND EVENTS, 2025-2026
• 5.15 TARIFF AND REGULATORY LANDSCAPE
  • 5.15.1 TARIFF ANALYSIS, 2024
  • 5.15.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.15.3 STANDARDS
• 5.16 IMPACT OF AI ON EXOSKELETON MARKET
  • 5.16.1 INTRODUCTION
  • 5.16.2 AI-SPECIFIC USE CASES
• 5.17 2025 US TARIFF IMPACT ON EXOSKELETON MARKET
  • 5.17.1 INTRODUCTION
  • 5.17.2 KEY TARIFF RATES
  • 5.17.3 PRICE IMPACT ANALYSIS
  • 5.17.4 KEY IMPACTS ON VARIOUS COUNTRIES/REGIONS
    • 5.17.4.1 US
    • 5.17.4.2 Europe
    • 5.17.4.3 Asia Pacific
  • 5.17.5 END-USE INDUSTRY IMPACT

6 EXOSKELETON MARKET, BY MATERIAL

• 6.1 INTRODUCTION
• 6.2 CARBON FIBER
  • 6.2.1 GROWING EMPHASIS ON LIGHTWEIGHT MATERIALS IN WEARABLE ROBOTICS TO DRIVE MARKET
• 6.3 METAL
  • 6.3.1 HIGH STRUCTURAL STRENGTH AND LOAD-BEARING CAPACITY TO DRIVE DEMAND
• 6.4 STEEL ALLOYS
  • 6.4.1 SUPERIOR DURABILITY IN HARSH WORK ENVIRONMENTS TO DRIVE MARKET
• 6.5 ALUMINUM
  • 6.5.1 CORROSION RESISTANCE AND LIGHTWEIGHT DESIGN TO FUEL SEGMENT GROWTH

7 EXOSKELETON MARKET, BY STRUCTURE

• 7.1 INTRODUCTION
• 7.2 RIGID EXOSKELETONS
  • 7.2.1 RISING DEMAND FOR REHABILITATION THERAPIES TO DRIVE MARKET
• 7.3 SOFT EXOSKELETONS
  • 7.3.1 INCREASING STARTUP FUNDING AND EXPANDING USE IN PERSONAL STRUCTURE TO DRIVE MARKET

8 EXOSKELETON MARKET, BY MOBILITY

• 8.1 INTRODUCTION
• 8.2 STATIONARY
  • 8.2.1 RISING DEMAND FOR REHABILITATION THERAPIES TO DRIVE MARKET
• 8.3 MOBILE
  • 8.3.1 RISING STARTUP FUNDING AND EXPANDING USE IN PERSONAL MOBILITY TO DRIVE MARKET

9 EXOSKELETON MARKET, BY BODY PART

• 9.1 INTRODUCTION
• 9.2 LOWER EXTREMITIES
  • 9.2.1 RISING PREVALENCE OF SPINAL CORD INJURIES TO BOOST MARKET DEMAND
• 9.3 UPPER EXTREMITIES
  • 9.3.1 ADVANCEMENTS IN PASSIVE AND LIGHTWEIGHT EXOSKELETONS TO DRIVE MARKET
• 9.4 FULL BODY
  • 9.4.1 ADOPTION IN COMPLEX REHABILITATION PROGRAMS AND RISING USE IN HEAVY INDUSTRIAL APPLICATIONS TO FUEL DEMAND

10 EXOSKELETON MARKET, BY COMPONENT

• 10.1 INTRODUCTION
• 10.2 SENSORS
  • 10.2.1 INTEGRATION OF AI AND ML TO BOOST DEMAND
  • 10.2.2 GYROSCOPES
  • 10.2.3 ACCELEROMETERS
  • 10.2.4 TILT SENSORS
  • 10.2.5 FORCE/TORQUE SENSORS
  • 10.2.6 POSITION SENSORS
  • 10.2.7 ELECTROMYOGRAPHY SENSORS
• 10.3 ACTUATORS
  • 10.3.1 COMPATIBILITY WITH ADVANCED CONTROLLERS AND SENSORS FOR REAL-TIME MOTION COORDINATION TO DRIVE MARKET
• 10.4 POWER SOURCES
  • 10.4.1 ADVANCEMENTS IN BATTERY TECHNOLOGIES TO BOOST MARKET
• 10.5 CONTROL SYSTEMS
  • 10.5.1 ADVANCEMENTS IN ML AND REAL-TIME DATA PROCESSING TO DRIVE MARKET
• 10.6 OTHER COMPONENTS

11 EXOSKELETON MARKET, BY TYPE

• 11.1 INTRODUCTION
• 11.2 POWERED EXOSKELETON
  • 11.2.1 RISING ADOPTION OF ROBOTIC ASSISTANCE IN REHABILITATION AND MOBILITY SUPPORT FOR PATIENTS TO FUEL MARKET GROWTH
  • 11.2.2 POWERED EXOSKELETONS, BY TECHNOLOGY
    • 11.2.2.1 Advancements in battery technology and energy-efficient actuators to fuel market growth
    • 11.2.2.2 Electric
    • 11.2.2.3 Pneumatic
    • 11.2.2.4 Hydraulic
• 11.3 PASSIVE EXOSKELETON
  • 11.3.1 INCREASING FOCUS ON WORKPLACE ERGONOMICS AND INJURY PREVENTION TO FUEL ADOPTION

12 EXOSKELETON MARKET, BY VERTICAL

• 12.1 INTRODUCTION
• 12.2 HEALTHCARE
  • 12.2.1 RISING FDA CLEARANCE AND STARTUP FUNDING TO FUEL GROWTH OF MEDICAL EXOSKELETONS SEGMENT
  • 12.2.2 REHABILITATION
  • 12.2.3 DISABILITY ASSISTANCE
  • 12.2.4 ELDERLY CARE
• 12.3 DEFENSE
  • 12.3.1 INCREASING DEMAND FOR ENHANCED SOLDIER PERFORMANCE AND OPERATIONAL EFFICIENCY TO COMPLEMENT MARKET GROWTH
  • 12.3.2 ENHANCED MOBILITY
  • 12.3.3 INJURY PREVENTION
  • 12.3.4 STEALTH AND TACTICAL OPERATIONS
• 12.4 INDUSTRIAL
  • 12.4.1 INCREASED FOCUS ON WORKPLACE SAFETY AND COMPLIANCE TO DRIVE MARKET
  • 12.4.2 HEAVY LIFTING
  • 12.4.3 REPETITIVE TASK ASSISTANCE
  • 12.4.4 POSTURAL SUPPORT
  • 12.4.5 LOGISTICS
  • 12.4.6 MATERIAL HANDLING
• 12.5 CONSTRUCTION
  • 12.5.1 INCREASING FOCUS ON WORKER HEALTH TO FUEL ADOPTION OF EXOSKELETONS
  • 12.5.2 LIFTING ASSISTANCE
  • 12.5.3 ENHANCED PRODUCTIVITY AND EFFICIENCY
• 12.6 OTHER VERTICALS

13 EXOSKELETON MARKET, BY REGION

• 13.1 INTRODUCTION
• 13.2 NORTH AMERICA
  • 13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 13.2.2 US
    • 13.2.2.1 Growing military focus on injury prevention and surge in startup funding to drive market
  • 13.2.3 CANADA
    • 13.2.3.1 Government contracts supporting defense applications to boost market
  • 13.2.4 MEXICO
    • 13.2.4.1 Strategic investments in hospital infrastructure to foster revenue growth
• 13.3 EUROPE
  • 13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 13.3.2 UK
    • 13.3.2.1 Government support through defense innovation program to propel market
  • 13.3.3 GERMANY
    • 13.3.3.1 Presence of leading exoskeleton manufacturers and startups to complement revenue growth
  • 13.3.4 FRANCE
    • 13.3.4.1 Strong public and private investment in MedTech to boost market
  • 13.3.5 ITALY
    • 13.3.5.1 Strong collaboration between research institutes and industry to drive market
  • 13.3.6 POLAND
    • 13.3.6.1 Strategic partnerships with global exoskeleton providers to drive market
  • 13.3.7 NORDICS
    • 13.3.7.1 Academic and institutional R&D in robotics to drive market
  • 13.3.8 REST OF EUROPE
• 13.4 ASIA PACIFIC
  • 13.4.1 MACRO ECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 13.4.2 CHINA
    • 13.4.2.1 Military investment in wearable robotics for logistics and mobility to boost market
  • 13.4.3 JAPAN
    • 13.4.3.1 Rapidly aging population and government support to create lucrative market growth opportunities
  • 13.4.4 SOUTH KOREA
    • 13.4.4.1 Advancements in lightweight, AI-integrated wearable robotics systems to drive market
  • 13.4.5 INDIA
    • 13.4.5.1 Military adoption for enhanced soldier endurance and injury prevention to boost market
  • 13.4.6 AUSTRALIA
    • 13.4.6.1 High healthcare spending to encourage adoption of advanced assistive technologies and boost demand
  • 13.4.7 INDONESIA
    • 13.4.7.1 High paraplegic population demanding affordable mobility rehabilitation solutions to drive market
  • 13.4.8 MALAYSIA
    • 13.4.8.1 Rising demand for rehabilitation devices that support patient mobility recovery to create growth opportunities
  • 13.4.9 THAILAND
    • 13.4.9.1 Government-backed research funding to boost exoskeleton technology development
  • 13.4.10 VIETNAM
    • 13.4.10.1 Increased research initiatives by domestic academic and medical institutions to drive market
  • 13.4.11 REST OF ASIA PACIFIC
• 13.5 REST OF THE WORLD
  • 13.5.1 MACROECONOMIC OUTLOOK FOR ROW
  • 13.5.2 MIDDLE EAST
    • 13.5.2.1 Bahrain
      • 13.5.2.1.1 Growing adoption of smart transportation and home automation to drive demand
    • 13.5.2.2 Kuwait
      • 13.5.2.2.1 Focus on improving healthcare accessibility and patient outcomes to fuel market
    • 13.5.2.3 Oman
      • 13.5.2.3.1 Rising prevalence of neurological and musculoskeletal disorders to drive market
    • 13.5.2.4 Qatar
      • 13.5.2.4.1 Strategic focus on defense modernization and soldier performance to increase market demand
    • 13.5.2.5 Saudi Arabia
      • 13.5.2.5.1 Vision 2030 focus on healthcare innovation and technology adoption to fuel market
    • 13.5.2.6 UAE
      • 13.5.2.6.1 Investment in R&D of intelligent robotic systems to drive market
    • 13.5.2.7 Rest of the Middle East
  • 13.5.3 SOUTH AMERICA
    • 13.5.3.1 Partnerships with global exoskeleton technology providers and manufacturers to support market
  • 13.5.4 AFRICA
  • 13.5.5 SOUTH AFRICA
    • 13.5.5.1 Focus on improving worker safety in high-risk mining operations to drive market
  • 13.5.6 OTHER AFRICAN COUNTRIES

14 COMPETITIVE LANDSCAPE

• 14.1 OVERVIEW
• 14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, JANUARY 2022-FEBRUARY 2025
• 14.3 REVENUE ANALYSIS, 2019-2023
• 14.4 MARKET SHARE ANALYSIS, 2024
• 14.5 COMPANY VALUATION AND FINANCIAL METRICS, 2024
• 14.6 BRAND/PRODUCT COMPARISON
• 14.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 14.7.1 STARS
  • 14.7.2 EMERGING LEADERS
  • 14.7.3 PERVASIVE PLAYERS
  • 14.7.4 PARTICIPANTS
  • 14.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 14.7.5.1 Company footprint
    • 14.7.5.2 Region footprint
    • 14.7.5.3 Vertical footprint
    • 14.7.5.4 Type footprint
    • 14.7.5.5 Body part footprint
• 14.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 14.8.1 PROGRESSIVE COMPANIES
  • 14.8.2 RESPONSIVE COMPANIES
  • 14.8.3 DYNAMIC COMPANIES
  • 14.8.4 STARTING BLOCKS
  • 14.8.5 COMPETITIVE BENCHMARKING: KEY STARTUPS/SMES, 2024
    • 14.8.5.1 Detailed list of startups/SMEs
    • 14.8.5.2 Competitive benchmarking of key startups/SMEs
• 14.9 COMPETITIVE SCENARIO
  • 14.9.1 PRODUCT LAUNCHES
  • 14.9.2 DEALS
  • 14.9.3 EXPANSIONS
  • 14.9.4 OTHER DEVELOPMENTS

15 COMPANY PROFILES

• 15.1 KEY PLAYERS
  • 15.1.1 EKSO BIONICS
    • 15.1.1.1 Business overview
    • 15.1.1.2 Products/Solutions/Services offered
    • 15.1.1.3 Recent developments
      • 15.1.1.3.1 Product launches
      • 15.1.1.3.2 Deals
      • 15.1.1.3.3 Other developments
    • 15.1.1.4 MnM view
      • 15.1.1.4.1 Key strengths/Right to win
      • 15.1.1.4.2 Strategic choices
      • 15.1.1.4.3 Weaknesses and competitive threats
  • 15.1.2 OTTOBOCK
    • 15.1.2.1 Business overview
    • 15.1.2.2 Products/Solutions/Services offered
    • 15.1.2.3 Recent developments
      • 15.1.2.3.1 Product launches
    • 15.1.2.4 MnM view
      • 15.1.2.4.1 Key strengths/Right to win
      • 15.1.2.4.2 Strategic choices
      • 15.1.2.4.3 Weaknesses and competitive threats
  • 15.1.3 DIH MEDICAL
    • 15.1.3.1 Business overview
    • 15.1.3.2 Products/Solutions/Services offered
    • 15.1.3.3 Recent developments
      • 15.1.3.3.1 Deals
    • 15.1.3.4 MnM view
      • 15.1.3.4.1 Key strengths/Right to win
      • 15.1.3.4.2 Strategic choices
      • 15.1.3.4.3 Weaknesses and competitive threats
  • 15.1.4 COMAU
    • 15.1.4.1 Business overview
    • 15.1.4.2 Products/Solutions/Services offered
    • 15.1.4.3 Recent developments
      • 15.1.4.3.1 Product launches
    • 15.1.4.4 MnM view
      • 15.1.4.4.1 Key strengths/Right to win
      • 15.1.4.4.2 Strategic choices
      • 15.1.4.4.3 Weaknesses and competitive threats
  • 15.1.5 MYOMO INC.
    • 15.1.5.1 Business overview
    • 15.1.5.2 Products/Solutions/Services offered
    • 15.1.5.3 Recent developments
      • 15.1.5.3.1 Product launches
      • 15.1.5.3.2 Other developments
    • 15.1.5.4 MnM view
      • 15.1.5.4.1 Key strengths/Right to win
      • 15.1.5.4.2 Strategic choices
      • 15.1.5.4.3 Weaknesses and competitive threats
  • 15.1.6 CYBERDYNE INC.
    • 15.1.6.1 Business overview
    • 15.1.6.2 Products/Solutions/Services offered
    • 15.1.6.3 Recent developments
      • 15.1.6.3.1 Expansions
  • 15.1.7 LIFEWARD LTD.
    • 15.1.7.1 Business overview
    • 15.1.7.2 Products/Solutions/Services offered
    • 15.1.7.3 Recent developments
      • 15.1.7.3.1 Deals
  • 15.1.8 HYUNDAI MOTOR GROUP ROBOTICS LAB.
    • 15.1.8.1 Business overview
    • 15.1.8.2 Products/Solutions/Services offered
    • 15.1.8.3 Recent developments
      • 15.1.8.3.1 Product launches
      • 15.1.8.3.2 Deals
  • 15.1.9 B-TEMIA
    • 15.1.9.1 Business overview
    • 15.1.9.2 Products/Solutions/Services offered
  • 15.1.10 REX BIONICS LTD.
    • 15.1.10.1 Business overview
    • 15.1.10.2 Products/Solutions/Services offered
• 15.2 OTHER PLAYERS
  • 15.2.1 ABLE HUMAN MOTION
  • 15.2.2 LAEVO EXOSKELETONS
  • 15.2.3 GERMAN BIONIC SYSTEMS GMBH
  • 15.2.4 LEVITATE TECHNOLOGIES, INC.
  • 15.2.5 FOURIER
  • 15.2.6 TREXO ROBOTICS
  • 15.2.7 WANDERCRAFT
  • 15.2.8 AGADE
  • 15.2.9 EUROPE TECHNOLOGIES
  • 15.2.10 GOGOA.EU
  • 15.2.11 ARCHELIS INC.
  • 15.2.12 P&S MECHANICS CO., LTD.
  • 15.2.13 RB3D
  • 15.2.14 JAPET MEDICAL DEVICES
  • 15.2.15 PROTESO S.R.L.

16 APPENDIX

• 16.1 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 16.2 CUSTOMIZATION OPTIONS
• 16.3 RELATED REPORTS
• 16.4 AUTHOR DETAILS